Stay updated on Pembrolizumab for EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for EGFR+ NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Added a new Locations section with California as a listed site and updated the revision from v3.3.2 to v3.3.3. The old California Locations link and the HHS Vulnerability Disclosure have been removed.
    Difference
    0.2%
    Check dated 2025-12-23T00:27:54.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now displays a revision label 'Revision: v3.3.2' replacing the previous 'Revision: v3.3.1'.
    Difference
    0.1%
    Check dated 2025-12-01T15:41:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Publications section now clarifies PubMed as the source of auto-filled articles and that they may not pertain to the study. The page revision tag has been updated to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T11:10:10.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A site-wide funding/operating status notice was removed. This does not modify the study details, eligibility criteria, or results displayed on the page.
    Difference
    0.4%
    Check dated 2025-11-17T06:08:15.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    No significant changes detected between the old and new screenshots; the page content and structure appear the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:55.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    Update adds a government-funding status notice and NIH Clinical Center operating details with a v3.2.0 revision, while removing the old v3.1.0 tag.
    Difference
    3%
    Check dated 2025-10-05T06:41:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for EGFR+ NSCLC Clinical Trial page.